Search hospitals > California > Beverly Hills
Pacific Oaks Medical Group
Claim this profileBeverly Hills, California 90211
Global Leader in Human Immunodeficiency Virus Infection
Conducts research for Infections
Conducts research for HIV
Conducts research for HIV/AIDS
Conducts research for Hepatitis A
44 reported clinical trials
0 medical researchers
Summary
Pacific Oaks Medical Group is a medical facility located in Beverly Hills, California. This center is recognized for care of Human Immunodeficiency Virus Infection, Infections, HIV, HIV/AIDS, Hepatitis A and other specialties. Pacific Oaks Medical Group is involved with conducting 44 clinical trials across 25 conditions. There are 0 research doctors associated with this hospital, such as .Top PIs
Clinical Trials running at Pacific Oaks Medical Group
HIV
Bictegravir + Lenacapavir
for HIV
The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC)/lenacapavir (LEN), fixed-dose combination (FDC) versus current therapy bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) FDC in people living with HIV-1 (PWH). The primary objective of this study is to learn how effective it is to switch to BIC/LEN FDC tablets versus continuing on B/F/TAF FDC tablets in virologically suppressed PWH.
Recruiting1 award Phase 3
DOR/ISL
for HIV
This is a randomized, active-controlled, double-blind clinical study designed to evaluate the antiretroviral activity, safety, and tolerability of doravirine/islatravir (DOR/ISL \[MK-8591A\]) in treatment-naïve participants with human immunodeficiency virus type 1 (HIV-1) infection. It is hypothesized that DOR/ISL is non-inferior to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) as assessed by the percentage of participants with HIV-1 ribonucleic acid (RNA) \<50 copies/mL at Week 48.
Recruiting1 award Phase 3
Bictegravir + Lenacapavir
for HIV
This trial is testing two HIV medications, bictegravir and lenacapavir, either separately or combined into one pill. It aims to see if these new treatments work better than current therapies for people living with HIV. These drugs help control HIV by stopping the virus from making more copies of itself. Bictegravir is a newly approved medication combined with other drugs, while lenacapavir is a long-acting medication recently approved in the EU.
Recruiting1 award Phase 2 & 36 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Pacific Oaks Medical Group?
Pacific Oaks Medical Group is a medical facility located in Beverly Hills, California. This center is recognized for care of Human Immunodeficiency Virus Infection, Infections, HIV, HIV/AIDS, Hepatitis A and other specialties. Pacific Oaks Medical Group is involved with conducting 44 clinical trials across 25 conditions. There are 0 research doctors associated with this hospital, such as .